본문 바로가기

Detection of HOXA9 gene methylation in tumor tissues and induced sputum samples from primary lung cancer patients

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q2
저널
CLINICAL CHEMISTRY AND LABORATORY MEDICINE49(4) · pp.699 · 2011
피인용
Web of Science 48
JCR IF
JCR 2010 2.069
ISSN
1434-6621

저자

  1. 황상현제1저자부산대학교, 의과대학, 의학과, 진단검사의학교실, KO
  2. 김기욱부산대학교, 부산대학교병원, 대학병원, KO
  3. Kim, Ji-Eun부산대학교, 의과대학, Dept Internal Med, Pusan Natl Univ Hosp, KO
  4. 김형회부산대학교, 의과대학, 의과학과, 의료정보학, KO
  5. 이민기교신저자부산대학교, 의과대학, 의학과, KO
  6. 이창훈부산대학교, 의과대학, 의학과, 병리학교실, KO
  7. 이상율부산대학교, 의과대학, 의과학과, 생화학교실, KO
  8. Oh, TaeJeong지노믹트리, KO
  9. An, Sungwhan지노믹트리, KO

초록

Background: Lung cancer is a leading cause of cancer deaths. Unfortunately, no effective early screening modality exists for lung cancer. We aimed to evaluate the prevalence of HOXA9 promoter methylation in tissue and induced sputum samples from Korean patients with lung cancer. Methods: Using pyrosequencing, HOXA9 methylation was analyzed for 40 pairs of primary lung cancer and normal tissues and 185 induced sputum specimens, including 76 patients with lung cancer. Results: The methylation of HOXA9 in lung cancer tissue was significantly higher compared with normal tissues (67.4%+/- 17.6% vs. 23.6%+/- 10.3%, respectively; p < 0.001). With a cut-off of > 45.6% of HOXA9 gene methylation in tissues, the sensitivity was 90.5% and the specificity was 97.5%. In induced sputum specimens, the HOXA9 gene in lung cancer patients was significantly more hypermethylated compared with patients with benign lung diseases and the healthy group (23.4%+/- 15.9%, 14.9%+/- 7.9%, and 9.7%+/- 5.0%, respectively; p < 0.001). Conclusions: The HOXA9 gene was hypermethylated in 32 of 40 tumors (80%), especially in early stages of lung cancer. HOXA9 methylation could be a potential biomarker to aid early detection and prognosis.

키워드

biomarkerDNA methylationearly detectionHOXA9 genelung cancerPROMOTER METHYLATIONDNA METHYLATIONHYPERMETHYLATIONSTATISTICSDIAGNOSISHOMEOBOXSMOKING

식별자

WoS UID
000289464200019